Loading company…
Or-Genix Therapeutics, Inc. develops biopharmaceuticals for rare diseases, based in Worcester, US.
Its CEO is Yael Schwartz, who has a background in biotechnology. In September 2017, the company raised an undisclosed amount of venture funding from Gore Range Capital, which it plans to use to advance its pipeline of rare disease products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in